| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
| (2,655) | 2,655 |
-
| | | Gross Profit |
-
| 2,655 | (2,655) |
-
| | | Operating Expenses | | Research Development | 6,025 | 7,170 | 5,705 | 6,110 | | Selling General and Administrative | 12,839 | 12,298 | 6,963 | 9,215 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,872) | (16,813) | (15,323) | (15,324) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 126 | 6 | 173 | 585 | | Earnings Before Interest And Taxes | (18,747) | (16,807) | (15,150) | (14,739) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (18,747) | (16,807) | (15,150) | (14,739) | | Income Tax Expense | (77) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,670) | (16,807) | (15,150) | (14,739) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,670) | (16,807) | (15,150) | (14,739) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,670) | ($16,807) | ($15,150) | ($14,739) |
|
0.51% Nasdaq 
Income Statement
